๐ฐApril 23 Market Fireworks: AI Memory Stocks Blast 8% as Tesla Caps Capex Warning โ S&P/Nasdaq at Records But Is the Rally Real or AI Hype Trap? ๐ฑ๐
Wall Street closed at fresh records today, but the action was driven by a clear AI infrastructure rotation amid mixed signals. Tesla pared gains after Elon Musk warned of heavy capex spending even as the company lifted 2026 plans by a quarter to fund AI and robotic dreams. Memory names exploded โ Micron and SanDisk jumped 8% while AMD soared 7% on AI boom tailwinds โ while Avis Budget crashed 38% on its own profit warning. Intel landed Tesla as its first major customer for 14A chip technology, SK Hynix reported a five-fold Q1 profit surge to record highs on AI demand, ServiceNow flagged Middle East deal delays, and IBMโs slower revenue growth fanned fresh AI worries. The Tiger Daily captures the selective strength in semiconductors and AI plays against broader caution. Emerging markets sho
BSX Gains on Repricing Story, Bulls Target Higher Levels
$Boston Scientific(BSX)$ $Boston Scientific (BSX) Soared +8.99%: Strong Rebound on Revised Guidance, Eyes $65 Breakout ๐ Latest Close Data ๐ Closed at $64.87 on 2026-04-23, surging +8.99% (+$5.35). The stock is now ~40.7% below its 52-week high of $109.50. Core Market Drivers ๐ก The stock rebounded sharply despite the company significantly lowering its 2026 revenue guidance, citing weaker sales in key product lines. The market viewed the new, more conservative targets as achievable and a potential "reset," creating a relief rally. The company also reiterated its capital allocation strategy, prioritizing strategic M&A over share buybacks. Technical Analysis ๐ Volume: Explosive volume of 40.4M shares (Volume Ratio: 2.59) confirms strong institutio
ใ04.13-04.19ใ๐Weekly Review | Does Taking Risks Lead to Doubling Your Profits? Is Zero Drawdown the Ultimate Goal? This Weekโs Top 2 Traders Use Data to Reveal the Answers!!
๐ข This Week's Report: Two Extreme Strategies, Both Outstanding 1๏ธโฃ jojoooo chose a high-risk, high-reward pathโโ He went all-in on one-sided call options, betting heavily on QQQ and SOFI to secure a 757.04% return. Despite a 43.88% drawdown, his results proved that daring to hold pays off. 2๏ธโฃ xx Harry xx , on the other hand, took a different pathโโ trading both long and short, profiting on every trade, and finishing with 100% cash in hand. With a 498.79% return and 0.00% drawdown, he steadily secured his spot on the podium. Some are willing to endure a drawdown of over 40% in exchange for explosive growth, while others pursue steady compounding returns with zero drawdown. ๐Letโs see exactly how they did it!! No. 1 Trader๐: jojoooo 1๏ธโฃ Core Trading Strategy : Ultra-short-term explosive gro
Underlying: $็พๅ ็งๆ(MU)$ View: Bullish, targeting the $500 resistance level with a potential move towards analyst target of $520. The stock is in a strong uptrend with high momentum, but RSI indicates overbought conditions, suggesting potential for consolidation or pullback before further gains. Strategy Type: Debit Spread / Directional Bullish Option Contract Portfolio: Buy 1 MU May 15, 2026 $495 Call Sell 1 MU May 15, 2026 $520 Call Max Gain & Loss: Max Gain = $2,500 (Difference in strikes - net debit). Max Loss = Net Debit Paid. Initial Cost/Credit: Debit of ~$9.50 (estimated from chain data: Buy $495C @ $9.85, Sell $520C @ $0.35 = Net Debit ~$9.50). Greek Exposure (Simulated): Delta: +0.10 (Moderate positive directional exposure) Theta: -0.03
$Intuitive Surgical(ISRG)$ $I-Sheng Industrial Corp. (ISRG) Stagnant at $1.50: Consolidation Phase, Awaiting Volume Catalyst ๐ Latest Close Data: ISGR closed at $1.50 on 2026-04-22 ET. The stock is currently trading near its recent lows, with a lack of significant directional movement in the latest session. ๐ฐ Core Market Drivers (Limited): No Company-Specific News: There is a notable absence of recent, high-impact news directly related to ISGR, suggesting a lack of immediate fundamental catalysts. General Market Sentiment: The provided news articles are broadly about general A-share market trends and "stock price theories," indicating a market environment focused on macro themes rather than individual small-cap stories like ISGR. ๐ Technical Analy
AKAN Explodes +214%, Speculative Surge Sends Shares Soaring
$Akanda Corp(AKAN)$ $Akanda Corp (AKAN) Explodes +214.15%: Penny Stock Rockets on Massive Volume, $12+ High Reclaimed ๐ Latest Close Data: Closed at $10.21 on 2026-04-23, surging a staggering +214.15% from the previous close. It reached a daily high of $12.33, still far below its 52-week high of $209.03. Core Market Drivers: The extreme volatility and surge appear to be driven by massive, concentrated trading activity rather than specific company news. The provided news data is largely irrelevant to AKAN, focusing on A average prices and other stocks, indicating no direct fundamental catalyst was reported. The move is characteristic of a low-float, high-volatility penny stock experiencing a speculative squeeze or pump. Technical Analysis: ๐ Volume
$NVIDIA(NVDA)$ see the price now! Flying again ! Nonstop making profit! $Tesla Motors(TSLA)$ later will fly a lot definitely! Let's see what will happen later!
$Advanced Micro Devices(AMD)$ $Advanced Micro Devices, Inc.(AMD) Surges +6.67%: AI Server CPU Narrative Powers 12-Day Rally, Testing $304 Highs ๐ ๐ Latest Close Data Closed at $303.46 (Apr 23), a powerful +6.67% gain, just $0.79 shy of its new 52-week high of $304.25. โก Core Market Drivers The rally is fueled by a structural re-rating of server CPUs in the AI era. Analysts highlight that agentic AI workloads are making CPUs "indispensable assets," shifting AMD's narrative beyond just GPU competition. A TrendForce report suggests CPU-to-GPU ratios could tighten from 1:8 to 1:1, signaling massive demand ahead. ๐ Technical Analysis Volume was strong at 49.1M shares (Vol Ratio: 1.23). The RSI(6) at 93.07 indicates extreme overbought conditions, signali
$Inhibrx Biosciences(INBX)$ $Inhibrx Biosciences(INBX) Soared +36.88%: Biotech Rocket Ignites on M&A Buzz, $115 Target in Sight ๐ Latest Close Data Closed at $115.09 on 2026-04-23, surging +36.88% with a massive intraday range of $100.00 - $155.29. The close is just $0.20 shy of its 52-week high of $155.29. Core Market Drivers The primary catalyst is a Reuters report indicating major pharmaceutical players, including Merck, are showing acquisition interest in the company's experimental cancer drug pipeline. This M&A speculation ignited a powerful rally. Technical Analysis The surge was accompanied by explosive volume (2.74M shares, ~7.8x avg), confirming strong institutional interest. The 6-day RSI rocketed to 88.19, entering extreme overb